Lung disease
Conditions
Interventions
Lidocaine spray 8%, 15 times spray (about 120 mg) is not administered.Bronchoscopy day (only 1 day)
Lidocaine spray 8%, 15 times spray (about 120 mg) is administered. Bronchoscopy day (only 1 day).
Sponsors
Izumi city general hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patients aged 20 years or older at the time of obtaining consent (regardless of gender) 2) Research subjects who have obtained sufficient written consent to participate in this research and then voluntarily consent to the document.
Exclusion criteria
Exclusion criteria: 1) Patients with a history of hypersensitivity to lidocaine or amide-type local anesthetics 2) Patients with a history of hypersensitivity to both midazolam and propofol 3) Patients with a history of hypersensitivity to fentanyl 4) Patients with pneumothorax 5) Pregnant / lactating patients 6) In addition, patients who are judged by the principal investigator to be inappropriate as research subjects
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Scale evaluation of procedure satisfaction at the time of examination judged by bronchoscopist | — |
Secondary
| Measure | Time frame |
|---|---|
| 1)Scale evaluation of patient's cough at the time of examination as judged by the bronchoscopist 2) Scale evaluation of cough at the time of own examination judged by the patient 2 hours after bronchoscopy 3) Scale evaluation of discomfort at the time of own examination judged by the patient 2 hours after bronchoscopy 4) Scale evaluation of pain at the time of own examination judged by the patient 2 hours after bronchoscopy 5) Bronchoscopy time 6) Total dose of lidocaine 7) Total dose of midazolam 8) Total dose of fentanyl 9) Total dose of propofol | — |
Countries
Japan
Contacts
Public ContactTakahiro Ueda
Izumi city general hospital Respiratory medicine
Outcome results
None listed